Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma.
Target Oncol. 2013 Jun;8(2):153-5
Authors: Lomax AJ, Yannakou CK, Rosenthal MA
Spinal metastases from glioblastoma are extremely rare and may be misdiagnosed leading to a delay in investigation and treatment. Patient outcomes are poor with a high morbidity and mortality. Metastases are seen in the context of increasing survival due to improvements in glioblastoma therapies. We report a case of a patient developing a thoracic spinal cord metastasis while receiving anti-angiogenesis therapy with bevacizumab.
PMID: 23430346 [PubMed – indexed for MEDLINE]